Skip to content
Recall Observatory FDA recall evidence

Drug product

Estradiol Vaginal Inserts, USP 10 mcg, packaged in a) 8 inserts/carton (NDC 0093-3223-08) and b) 18 inserts/carton (NDC 0093-3223-97), Rx only, Teva Women's Health, Inc. Subsidiary of Teva Pharmaceuticals USA, North Wales, PA 19454.

D-0620-2018

March 19, 2018

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 79542
Status
Terminated
Classification
Class II
Quantity
640,486 vaginal inserts
Official record key
drug-enforcement:D-0620-2018

Official wording

Reason: Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.

Code information: Lot #: a) 33812545A, 33812546A, 33812774A, Exp. 12/2018; 33812775A, Exp. 01/2019; 33812776A, 33812777A, Exp. 05/2019; 33813786A, 33813868A, Exp. 7/2019; 33813974A, 33814058A, Exp. 09/2019; 33814113A, Exp. 01/2019; b) 33812547A, 33813361A,33813676A, Exp. 1/2019

Distribution pattern: Distributed within the United States and Puerto Rico.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.

Field note

Send feedback

We'll only use this to respond to your feedback.